| Clewiston Nursing & Rehabilitation | |
| 301 South Gloria St, Clewiston, Florida 33440 | |
| (863) 983-5123 | |
| Name | Clewiston Nursing & Rehabilitation |
|---|---|
| Location | 301 South Gloria St, Clewiston, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 155 |
| Occupancy Rate | 78% |
| Medicare ID (CCN) | 105462 |
| Legal Business Name | Clewiston Nursing & Rehabilitation Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1174999478 |
| Organization Name | CLEWISTON NURSING & REHABILITATION, LLC |
| Address | 301 S Gloria St, Clewiston, FL 33440 |
| Phone Number | 863-983-5123 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
| NPI Number | 1447024013 |
| Organization Name | CLEWISTON NURSING AND REHAB OPCO LLC |
| Address | 301 S Gloria St, Clewiston, FL 33440 |
| Phone Number | 863-983-5123 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
| NPI Number | 1457090730 |
| Organization Name | CLEWISTON SNF OPERATIONS LLC |
| Address | 301 S Gloria St, Clewiston, FL 33440 |
| Phone Number | 863-983-5123 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
| NPI Number | 1679579965 |
| Organization Name | SA-CLEWISTON, LLC |
| Doing Business As | PALM TERRACE OF CLEWISTON |
| Address | 301 S Gloria St, Clewiston, FL 33440 |
| Phone Number | 863-983-5123 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $16957 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 14.95 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.49 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 24.8 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.23 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.03 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.35 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.59 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.65 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 88.58 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.65 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16.97 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.43 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.67 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.3 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 86.03 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 75.19 | 82.93 |
News Archive
MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address the unmet medical need of preventing recurrent cancer, announces that it has received the Phase 2 portion of the Small Business Innovation Research Grant from the National Cancer Institute under the agency's Streamlined Non-competing Award Procedures.
Personal care products that we use everyday contain chemicals that act as endocrine disruptors, which hinder the normal functions of our hormone systems. Phthalates, also known as plasticizers, are added to plastics to make them flexible to mold into shapes for product packaging and as fragrance for perfumes and air fresheners. Parabens are added to personal care products, such as cosmetics, to extend shelf-life and eliminate fungi and bacteria.
Volume 11, Issue 23 of @Oncotarget reported that tissue microarrays of 132 patients were stained for survivin using immunohistochemistry and correlated with outcomes.
InSite Vision Incorporated today announced that Inspire Pharmaceuticals, its commercial partner for AzaSite (azithromycin ophthalmic solution) 1% in the U.S and Canada, has committed to increasing production of AzaSite in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
› Verified 9 days ago
Clewiston Nursing & Rehabilitation Location: 301 South Gloria St, Clewiston, Florida 33440 Phone: (863) 983-5123 |